Lung Bioengineering is part of United Therapeutics' wholly-owned Lung Biotechnology PBC public benefit subsidiary, which is chartered with the express purpose "to address the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Bioengineering owns and operates a laboratory in Silver Spring, Maryland, dedicated to performing centralized ex-vivo lung perfusion procedures designed to provide extended preservation and assessment of lungs otherwise deemed unsuitable for transplant.
| Website | http://www.lungbioengineering.com |
| Revenue | $4 million |
| Employees | 2 (2 on RocketReach) |
| Address | 1015 Spring St, Silver Spring, Maryland 20910, US |
| Phone | (240) 650-2290 |
| Industry | Retail |
| Competitors | Edwards Lifesciences, Medtronic, Kite Pharma, Organogenesis, Lorem Cytori USA, Inc, Athersys, Tissue Regenix Group, InVivo Therapeutics, CareCentric, Eden Biologics +34 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Lung Bioengineering employee's phone or email?
Lung Bioengineering Questions
The Lung Bioengineering annual revenue was $4 million in 2026.
2 people are employed at Lung Bioengineering.
Lung Bioengineering is based in Silver Spring, Maryland.
The NAICS codes for Lung Bioengineering are [339, 33].
The SIC codes for Lung Bioengineering are [38, 384].
